Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spruce Capital Partners is a venture capital management and private equity firm focused on early-stage investments in innovative life sciences sectors including agriculture, agtech, biotech, bio-GreenTech, food & nutrition. The fund co-manages MLS Capital Fund II and has invested in notable startups such as Evolve Biosystems (microbiome health), Provivi (pheromone crop protection), Inscripta (CRISPR gene editing), GreenLight Biosciences (RNA production for pest control), and others. Their investments target positive impacts on human health and the environment through advanced biotechnologies
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spruce Capital Partners.